ARCHIVES

Professional Societies: Three Groups To File brief In Fisher’s Appeal

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

Congress enacts Medicare reform, bill cuts oncology reimbursement.

November 28, 2003